+ 500
million
people around the world are affected by cardiovascular diseases (CVD) every year
Source: WHR 2023
20,5
million
people died from CVDs in 2021 (an estimated)
1/3
of all global deaths
cardiovascular diseases accounted for close to a third of all global deaths
85%
of these deaths
were due to heart attack and stroke
Clinical Excellence

Prix Galien

Hexacath France received the Prix Galien 2021 in the “Medical Device” category with TiTAN OPTiMAX indicated in the treatment of coronary syndromes

Pre-Clinical
Experience

Before committing to the development of new technologies, Hexacath relied on a large body of pre-clinical evidence and fundamental in vitro and in vivo studies.

Clinical Evidence

Over almost 2 decades have been necessary to gather an impressive amount of clinical evidence demonstrating the Titan bioactive stent Superiority in ACS drug-eluting stent in Acute Coronary Syndrome patients and the interest of the continuous thermodilution technology using the RayFlow microcatheter to assess Coronary Microvascular Disease.

Locations
FRANCE
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Switzerland
  • Serbia
  • Bosnia
  • Finland
MIDDLE EAST
  • Israël
    Saudi Arabia (in progress)
AMERICA
  • USA
    Mexico
ASIA
  • India
    Japan (in progress)
    Vietnam
    South Korea
    Taiwan
  • Hong Kong
    Singapore (in progress)
  • Indonesia
  • Malaysia
  • Pakistan (in progress)
  • Thailand (in progress)
Events

EuroPCR

The World-Leading Course in interventional cardiovascular medicine #EuroPCR Paris, France Palais des Congrès